Prometheus Biosciences Inc
NASDAQ:RXDX
Prometheus Biosciences Inc
NASDAQ:RXDX
Price:
199.92 USD
0.09%
Updated:
May 17, 2024
Cash Flow Statement
Cash Flow Statement
Prometheus Biosciences Inc
Prometheus Biosciences Inc
Currency: USD
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
(19)
|
(46)
|
(76)
|
(108)
|
(123)
|
(133)
|
(142)
|
(151)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Other Non-Cash Items |
7
|
15
|
17
|
15
|
18
|
16
|
19
|
21
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
5
|
8
|
13
|
20
|
7
|
12
|
(1)
|
(4)
|
|
| Cash from Operating Activities |
(6)
N/A
|
(23)
-274%
|
(45)
-96%
|
(74)
-63%
|
(97)
-32%
|
(104)
-7%
|
(123)
-18%
|
(133)
-8%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(2)
|
|
| Other Items |
0
|
0
|
0
|
0
|
(116)
|
(181)
|
(401)
|
(593)
|
|
| Cash from Investing Activities |
1
N/A
|
0
-67%
|
(0)
N/A
|
(2)
-22 288%
|
(118)
-6 509%
|
(184)
-55%
|
(404)
-120%
|
(595)
-47%
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
264
|
264
|
265
|
1
|
16
|
91
|
595
|
651
|
|
| Net Issuance of Debt |
(7)
|
(15)
|
(15)
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
(17)
|
(17)
|
(17)
|
(1)
|
(1)
|
(3)
|
(33)
|
(36)
|
|
| Cash from Financing Activities |
240
N/A
|
232
-3%
|
232
+0%
|
(9)
N/A
|
7
N/A
|
87
+1 092%
|
562
+543%
|
615
+9%
|
|
| Change in Cash | |||||||||
| Net Change in Cash |
234
N/A
|
209
-11%
|
187
-10%
|
(84)
N/A
|
(208)
-148%
|
(201)
+4%
|
35
N/A
|
(114)
N/A
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(7)
N/A
|
(24)
-263%
|
(46)
-93%
|
(76)
-64%
|
(100)
-32%
|
(107)
-7%
|
(126)
-18%
|
(136)
-8%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
